Podcast: Thermo Fisher Talks Regulatory Experience With Oncomine

Laboratory
Thermo Fisher's Oncomine Dx Target Test is the first multi-drug next-generation sequencing test approved by US FDA • Source: Thermo Fisher Scientific
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation